Literature DB >> 19807502

Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries.

A Harris1, M Buxton, B O'Brien, F R Drummond.   

Abstract

Year:  2001        PMID： 19807502     DOI： 10.1586/14737167.1.1.7

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN： 1473-7167            Impact factor:   2.217


× No keyword cloud information.
  8 in total

1.  A proposed model for economic evaluations of major depressive disorder.

Authors:  Hossein Haji Ali Afzali; Jonathan Karnon; Jodi Gray
Journal:  Eur J Health Econ       Date:  2011-06-02

2.  Cost-effectiveness league tables: valuable guidance for decision makers?

Authors:  Josephine Mauskopf; Frans Rutten; Warren Schonfeld
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Unravelling drug reimbursement outcomes: a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision making.

Authors:  Margreet Franken; Fredrik Nilsson; Frank Sandmann; Anthonius de Boer; Marc Koopmanschap
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

4.  The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.

Authors:  Mohammed S Alsultan
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

5.  The increasingly complex fourth hurdle for pharmaceuticals.

Authors:  Joshua Cohen; Elly Stolk; Maartje Niezen
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 6.  Pharmacoeconomic education for pharmacy students in bosnia and herzegovina.

Authors:  Tarik Catić; Selma Skrbo
Journal:  Mater Sociomed       Date:  2013-11-24

7.  The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.

Authors:  Yot Teerawattananon; Steve Russell
Journal:  BMC Health Serv Res       Date:  2008-09-26       Impact factor: 2.655

8.  Do coxibs reduce prescription of gastroprotective agents? Results of a record linkage study.

Authors:  Giulio Formoso; Angelo Menna; Claudio Voci; Andrea Violante; Nicola Magrini
Journal:  Cost Eff Resour Alloc       Date:  2006-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.